Amneal Pharmaceuticals Stock Forward View - Simple Moving Average
| AMRX Stock | USD 14.82 0.19 1.30% |
Amneal Stock outlook is based on your current time horizon.
At this time the relative strength index (rsi) of Amneal Pharmaceuticals' share price is below 20 . This suggests that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
Using Amneal Pharmaceuticals hype-based prediction, you can estimate the value of Amneal Pharmaceuticals Class from the perspective of Amneal Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors.
The Simple Moving Average forecasted value of Amneal Pharmaceuticals Class on the next trading day is expected to be 14.82 with a mean absolute deviation of 0.18 and the sum of the absolute errors of 10.79. Amneal Pharmaceuticals after-hype prediction price | USD 15.27 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Amneal Pharmaceuticals to cross-verify your projections. Amneal Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine Amneal price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Amneal using various technical indicators. When you analyze Amneal charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Amneal Pharmaceuticals Simple Moving Average Price Forecast For the 18th of February 2026
Given 90 days horizon, the Simple Moving Average forecasted value of Amneal Pharmaceuticals Class on the next trading day is expected to be 14.82 with a mean absolute deviation of 0.18, mean absolute percentage error of 0.05, and the sum of the absolute errors of 10.79.Please note that although there have been many attempts to predict Amneal Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Amneal Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Amneal Pharmaceuticals Stock Forecast Pattern
| Backtest Amneal Pharmaceuticals | Amneal Pharmaceuticals Price Prediction | Research Analysis |
Amneal Pharmaceuticals Forecasted Value
In the context of forecasting Amneal Pharmaceuticals' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Amneal Pharmaceuticals' downside and upside margins for the forecasting period are 13.23 and 16.41, respectively. We have considered Amneal Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of Amneal Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Amneal Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 111.4365 |
| Bias | Arithmetic mean of the errors | -0.0835 |
| MAD | Mean absolute deviation | 0.183 |
| MAPE | Mean absolute percentage error | 0.014 |
| SAE | Sum of the absolute errors | 10.795 |
Predictive Modules for Amneal Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Amneal Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Amneal Pharmaceuticals After-Hype Price Density Analysis
As far as predicting the price of Amneal Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Amneal Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Amneal Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Amneal Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting Amneal Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Amneal Pharmaceuticals' historical news coverage. Amneal Pharmaceuticals' after-hype downside and upside margins for the prediction period are 13.68 and 16.86, respectively. We have considered Amneal Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Amneal Pharmaceuticals is very steady at this time. Analysis and calculation of next after-hype price of Amneal Pharmaceuticals is based on 3 months time horizon.
Amneal Pharmaceuticals Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Amneal Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Amneal Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Amneal Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.47 | 1.59 | 0.00 | 0.07 | 0 Events / Month | 4 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
14.82 | 15.27 | 0.53 |
|
Amneal Pharmaceuticals Hype Timeline
Amneal Pharmaceuticals is presently traded for 14.82. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.07. Amneal is projected to increase in value after the next headline, with the price projected to jump to 15.27 or above. The average volatility of media hype impact on the company the price is insignificant. The price jump on the next news is projected to be 0.53%, whereas the daily expected return is presently at 0.47%. The volatility of related hype on Amneal Pharmaceuticals is about 1104.17%, with the expected price after the next announcement by competition of 14.89. The company reported the previous year's revenue of 2.79 B. Net Loss for the year was (73.88 M) with profit before overhead, payroll, taxes, and interest of 1.09 B. Given the investment horizon of 90 days the next projected press release will be in 5 to 10 days. Check out Historical Fundamental Analysis of Amneal Pharmaceuticals to cross-verify your projections.Amneal Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to Amneal Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict Amneal Pharmaceuticals' future price movements. Getting to know how Amneal Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Amneal Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| LNTH | Lantheus Holdings | 0.00 | 0 per month | 0.81 | 0.26 | 3.75 | (2.19) | 8.01 | |
| SUPN | Supernus Pharmaceuticals | 0.00 | 0 per month | 1.32 | 0.1 | 3.24 | (2.65) | 7.52 | |
| INDV | Indivior PLC Ordinary | (0.16) | 9 per month | 1.32 | 0.08 | 3.08 | (2.48) | 7.35 | |
| TLX | Telix Pharmaceuticals Limited | 0.00 | 0 per month | 0.00 | (0.19) | 4.24 | (5.54) | 16.50 | |
| PRGO | Perrigo Company PLC | 1.09 | 8 per month | 1.91 | 0.01 | 3.75 | (2.99) | 7.24 | |
| SLNO | Soleno Therapeutics | 0.59 | 9 per month | 0.00 | (0.11) | 5.07 | (4.39) | 15.78 | |
| MIRM | Mirum Pharmaceuticals | 0.69 | 10 per month | 1.81 | 0.20 | 4.60 | (3.68) | 16.13 | |
| NVST | Envista Holdings Corp | (0.50) | 10 per month | 1.31 | 0.20 | 4.21 | (2.87) | 22.69 | |
| BHC | Bausch Health Companies | (0.07) | 9 per month | 0.00 | (0.07) | 3.74 | (4.63) | 21.07 | |
| DYN | Dyne Therapeutics | (0.20) | 9 per month | 0.00 | (0.08) | 7.01 | (5.89) | 26.40 |
Other Forecasting Options for Amneal Pharmaceuticals
For every potential investor in Amneal, whether a beginner or expert, Amneal Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Amneal Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Amneal. Basic forecasting techniques help filter out the noise by identifying Amneal Pharmaceuticals' price trends.Amneal Pharmaceuticals Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Amneal Pharmaceuticals stock to make a market-neutral strategy. Peer analysis of Amneal Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Amneal Pharmaceuticals by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Amneal Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Amneal Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Amneal Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Amneal Pharmaceuticals stock market strength indicators, traders can identify Amneal Pharmaceuticals Class entry and exit signals to maximize returns.
Amneal Pharmaceuticals Risk Indicators
The analysis of Amneal Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Amneal Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting amneal stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.29 | |||
| Semi Deviation | 1.07 | |||
| Standard Deviation | 1.59 | |||
| Variance | 2.53 | |||
| Downside Variance | 2.48 | |||
| Semi Variance | 1.14 | |||
| Expected Short fall | (1.56) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Amneal Pharmaceuticals
The number of cover stories for Amneal Pharmaceuticals depends on current market conditions and Amneal Pharmaceuticals' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Amneal Pharmaceuticals is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Amneal Pharmaceuticals' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Amneal Pharmaceuticals Short Properties
Amneal Pharmaceuticals' future price predictability will typically decrease when Amneal Pharmaceuticals' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Amneal Pharmaceuticals Class often depends not only on the future outlook of the potential Amneal Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Amneal Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 309 M | |
| Cash And Short Term Investments | 112.4 M |
Additional Tools for Amneal Stock Analysis
When running Amneal Pharmaceuticals' price analysis, check to measure Amneal Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amneal Pharmaceuticals is operating at the current time. Most of Amneal Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Amneal Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amneal Pharmaceuticals' price. Additionally, you may evaluate how the addition of Amneal Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.